Population
Susceptible pigs
Design
Preclinical
Follow-up
28 days
Authors
Loading...
Does not support cross-protection against SVD despite transient antibodies in pigs; leaves open mechanisms of serological cross-reactivity for further study.
Coxsackie virus type B5 does not cause clinical disease in pigs and does not confer protective immunity against Swine Vesicular Disease despite their close serological relationship.
Garland et al. (1974) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: